ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.

The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

As we get older, our cognitive abilities can decline. However, reading has surprising benefits for our brain health ...

Sleep science is rewriting the rules on rest, exposing myths about sleep cycles, alarms, and nutrition while offering a path ...

Taking longer to get to deep sleep or REM sleep can disrupt memory consolidation and emotional processing, affecting overall ...

Sleep apnea, which can include snoring as the body struggles to get enough air during the night, may lead to a higher risk of cardiovascular and metabolic diseases. Insufficient or poor-quality sleep ...

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,569.2 Million by 2030.

A burlesque boss accused of raping a woman in his Sydney apartment has been acquitted after arguing he suffered from an ...

A good night’s sleep is just as vital as a balanced diet and regular exercise. Poor sleep affects mood, brain function, and ...

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, ...

A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox ...

Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...